- Reported purity
- 99.8%99.5%+
- Test date
- Jan 29, 2026
- Laboratory named
- Vanguard Laboratory
Lot details
Clear Cap
Market
L
Popular
44% above market
on 19 popular peptides
Catalog
41% above market
$$$ price level · 33 listings
Peptides
27
19 popular carried
COA coverage, in stock
4 of 26
15% of in-stock products · in-stock vendor median 54%
Cheapest on
- CJC-1295 (no DAC)▼ 48%
- Ipamorelin▼ 21%
- Semax▼ 13%
Pricier on
- 5-Amino-1MQ▲ 1197%
- SLU-PP-332▲ 786%
- IGF-LR3▲ 381%
Price check
Listed prices at Licensed Peptides against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
Epitalon10 mg vial · lowest elsewhere $1.68/mg at Peptide Works▲ 130%$9.20/mgNAD+500 mg vial · lowest elsewhere $0.07/mg at Ion Peptide▲ 86%$0.26/mgTesamorelin10 mg vial · lowest elsewhere $3.90/mg at retaone▲ 75%$13.10/mgSS-3110 mg vial · lowest elsewhere $2.70/mg at retaone▲ 69%$10/mgPinealon10 mg vial · lowest elsewhere $2.50/mg at Grey Axis Research▲ 67%$7.70/mgCJC-1295 (with DAC)5 mg vial · lowest elsewhere $7.80/mg at peptira▲ 63%$18.40/mg
Below the market median on 5 of 24 comparable listings, above it on 19. Typical listing: 37% above market. Showing the 6 largest differences.
Popular peptides
19 of 22 carriedFull catalog (27)
Product documentation
Licensed Peptides COA coverage
Current certificates are on file for 4 of 27 tracked peptide products from Licensed Peptides. The public index contains 7 documents. Reported test dates in this set run from Oct 9, 2025 through Jan 29, 2026. That coverage figure counts the full tracked catalogue for Licensed Peptides, including products that are currently out of stock, so it can differ from the in-stock figure above.
- Product coverage
- 4 of 27
- Tested in past year
- 3 of 4
- Older records
- 0
- Most named lab
- Vanguard Laboratory
15% · tracked-vendor median 54%
Based on the printed test date.
Printed date is over 18 months old.
75% of current records that name a lab.
4 current records
View COA
- Reported purity
- 99.8%99.5%+
- Test date
- Jan 29, 2026
- Laboratory named
- Vanguard Laboratory
Lot details
Yellow Cap
- Reported purity
- 99.896%99.5%+
- Test date
- Oct 9, 2025
- Laboratory named
- JANOSHIK
Lot details
reta10100926g
- Reported purity
- 99.8%99.5%+
- Test date
- Not reported
- Laboratory named
- Vanguard Laboratory
Lot details
Clear Cap / White Cap
| Printed lab | Certificate | |||
|---|---|---|---|---|
| Epitalon | Vanguard Laboratory | Jan 29, 2026 | 99.8%99.5%+ | View COA |
| Retatrutide | Vanguard Laboratory | Jan 29, 2026 | 99.8%99.5%+ | View COA |
| BPC-157 | JANOSHIK | Oct 9, 2025 | 99.896%99.5%+ | View COA |
| GHK-Cu | Vanguard Laboratory | Not reported | 99.8%99.5%+ | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These numbers measure document coverage only. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.